This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Methods We carried out a case-control study to identify circulating miRNAs associated with CHCM. We performed a clinical, echocardiographic, and laboratory evaluation and profiled circulating miRNA in the serum samples. Results Differences between groups were observed in clinical variables and in the analysis of miRNAs.
Circulation, Ahead of Print. The coronary care unit gradually evolved from a focus on rapid resuscitation from ventricular arrhythmias in acute myocardial infarction into a comprehensive cardiac intensive care unit designed to care for the sickest patients with cardiovascular disease.
Circulation: Cardiovascular Interventions, Ahead of Print. No significant differences were observed in documented arrhythmias, bleeding, or stroke. Background:Nickel-containing devices, such as the Amplatzer PFO Occluder and Gore Cardioform Septal Occluder (GSO), are used for transcatheter patent foramen ovale (PFO) closure.
Circulation, Ahead of Print. In addition, exposure of the fetus or neonate to either persistent arrhythmias or antiarrhythmic medications may have yet-to-be-determined long-term developmental consequences. Disorders of the cardiac rhythm may occur in both the fetus and neonate.
A pharmaceutical gene therapy has shown promise in treating calmodulinopathy, a rare and hard-to-treat heart arrhythmia, according to a study published Aug. 19 in Circulation.
The American Heart Association has released a scientific statement providing guidance on the management of patients with COVID-19-related cardiac arrhythmias and autonomic dysfunction. 14 in Circulation. The statement was published Oct.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Evidence from experimental systems and patients indicates that ventricular myocytes inPKP2arrhythmogenic cardiomyopathy have greatly reduced electrical coupling at gap junctions and reduced Na+current density.
BackgroundAtrial dysfunction is a risk factor for atrial arrhythmia and can be detected by atrial strain imaging in patients with biventricular circulation. Newonset and recurrent atrial arrhythmias were ascertained from baseline encounter to last followup.
Circulation, Volume 150, Issue Suppl_1 , Page A4138334-A4138334, November 12, 2024. Ischemic cardiomyopathy, a severe cardiac condition resulting from prolonged myocardial ischemia, is characterized by ventricular dilation, dysfunction, and an increased risk of life-threatening arrhythmias.
A pacemaker modified for newborns' tiny bodies safely and effectively stabilized their heart rhythms for up to two years, according to new research published in Circulation: Arrhythmia and Electrophysiology.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Epicardial radiofrequency catheter ablation (RFCA) of idiopathic ventricular arrhythmias (VAs) originating from the left ventricular summit (LVS) is challenging because of the anatomic barriers.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. In 490 full-text EHR notes from 125 patients with prior life-threatening heart rhythm disorders, we asked GPT-4-turbo to identify recurrent arrhythmias distinct from prior events and tested 220 563 queries.
The findings, led by investigators in the Smidt Heart Institute at Cedars-Sinai, published in Circulation: Arrhythmia and Electrophysiology. Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib).
That’s far higher than previous estimates, including a pair of JAMA and Circulation studies that estimated nationwide AFib rates of 2.26M and 5.1M back in 2000, and forecasted that 3.33M and 7.5M adults would have AFib by 2020.
Circulation, Ahead of Print. Cardiac sarcoidosis is an infiltrative cardiomyopathy that results from granulomatous inflammation of the myocardium and may present with high-grade conduction disease, ventricular arrhythmias, and right or left ventricular dysfunction.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Population genomic screening for desmosome variants associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) may facilitate early disease detection and protective intervention.
Torsade de pointes (TdP) was not a rare arrhythmia in Israel during the 1970s–1980s as many patients, mainly with atrial fibrillation (AF), were treated with QT-prolonging antiarrhythmic drugs. Our experience was published in 1981 in Circulation.1
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. CONCLUSIONS:Similarly high rates of durable PVI and arrhythmia-free survival were achieved with 90W and 50W. No complications occurred. There was no difference in 12-month atrial fibrillation-free survival between the 90W and 50W groups (P=0.2).CONCLUSIONS:Similarly
Circulation, Volume 150, Issue Suppl_1 , Page A4136459-A4136459, November 12, 2024. Ventricular arrhythmias (VA), such as ventricular fibrillation and ventricular tachycardia, are the major causes of mortality among patients with CAD.
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Circulation. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.
Circulation, Volume 150, Issue Suppl_1 , Page ASu505-ASu505, November 12, 2024. The targeted Automated External Defibrillator (AED) program in the Sao Paulo Metro has yielded promising results in improving survival rates for individuals experiencing out-of-hospital cardiac arrest (OHCA) due to ventricular arrhythmias.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content